Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Included in this report:
Analysis and interpretation of EU and US regulation relating to branded generic and generic orally inhaled products
Economic assessment (NPV analysis) of branded generic and generic Advair and Symbicort competitors that will launch in the EU and US
Medtech Insight: global medical technology news & analysis
05 Jun 2023
Navigating Europe’s increasingly complex maze of regulations was the topic du jour at this year’s MedTech Forum conference. Despite growing...
Pink Sheet: global policy and regulatory coverage
By Neena Brizmohun 02 Jun 2023
Bristol Myers Squibb and Pfizer both asked the health technology assessment body NICE to evaluate their respective drugs, Camzyos and...
HBW Insight: Health, Beauty and Wellness
By David Ridley 02 Jun 2023
Europe's consumer health industry is faced with proliferating regulations under the EU's Green Deal policy program. Proposed revisions to the...
Request a Demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
